Latest Share Price Volatility News

Kinterra Capital GP Corp. II has extended its takeover offer for New World Resources Limited, pushing the deadline to August 22, 2025. This marks the sixth extension in the ongoing bid process.

Rhythm Biosciences has responded to an ASX price query following a sudden surge in its share price and trading volume, confirming no undisclosed information is driving the activity.

Donaco International shareholders have overwhelmingly approved a scheme of arrangement for On Nut Road Limited to acquire the company at a significant premium, setting the stage for a major ownership change pending court approval.

PointsBet Holdings Limited has issued a Target’s Statement recommending shareholders accept MIXI Australia’s $1.20 per share all-cash takeover offer, highlighting a significant premium and rejecting a rival scrip bid from Betr Entertainment.

Chariot Corporation Ltd has had its trading suspension lifted following an announcement about a proposed acquisition, signaling renewed market interest.

QPM Energy Limited has launched a $2 million Share Purchase Plan at $0.031 per share, matching a recent $10 million placement, to support the development of its Isaac Energy Hub. Eligible shareholders in Australia and New Zealand can participate until mid-July.

Envirosuite Limited shareholders are invited to vote on a $132.2 million acquisition proposal by Ideagen EVS BidCo Pty Limited, with the Envirosuite Board unanimously recommending approval. The scheme offers a significant premium to recent trading prices and is supported by an independent expert report deeming it fair and reasonable.

Domain Holdings Australia Limited is set for acquisition by CoStar Group at $4.43 per share, a premium supported by the Domain Board, Independent Expert, and controlling shareholder Nine. The scheme awaits shareholder and court approval, with a meeting scheduled for August.

Redox Limited has dismissed any undisclosed information behind its recent share price plunge, attributing the volatility to analyst downgrades and broader economic concerns.

TruScreen Group Limited has launched a NZ$1.22 million Share Purchase Plan offering discounted shares to eligible investors, aiming to fuel growth in key international markets and public health initiatives.

Unith Ltd has responded to an ASX price query following unusual trading activity, denying undisclosed information and pointing to a successful recent roadshow as a potential factor.

Mayne Pharma has clarified why it did not disclose an FDA Untitled Letter to the market despite sharing it with its scheme bidder, reaffirming compliance with ASX rules amid recent share price volatility.